封面
市場調查報告書
商品編碼
1074782

數位病理的全球市場:各類型(獸醫病理學,人體病理學),各產品(軟體,服務),各部署,各終端用戶,各地區分析 - 預測(到2028年)

Digital Pathology Market Forecasts to 2028 - Global Analysis By Type (Veterinary Pathology, Human Pathology), Product (Software, Services), Deployement, End User, and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

全球數位病理的市場規模,2021年為7億6,159萬美金,在預測期間內預計以15.2%的年複合成長率發展,至2028年達到20億5,063萬美元。

本報告提供全球數位病理市場調查,市場的推動因素與阻礙因素,市場機會,COVID-19影響,各類型、各產品、各部署、各用途、各終端用戶、各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 序文

第3章 市場趨勢分析

  • 促進因素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 產品分析
  • 用途分析
  • 終端用戶分析
  • 新興市場
  • COVID-19影響

第4章 波特的五力分析

第5章 全球數位病理市場:各類型

  • 獸醫病理學
  • 人體病理學

第6章 全球數位病理市場:各產品

  • 軟體
    • 獨立軟體
    • 整合軟體
  • 儲存、通信系統
  • 服務
    • 維護、檢驗服務
    • 安裝、整合服務
    • 諮詢服務
  • 設備
    • 組織學設備
    • 大廳幻燈片掃描機
    • 臨床顯微鏡
    • 遠程病理學
    • 組織微陣列

第7章 全球數位病理市場:各部署

  • 內部部署
  • 雲端基礎

第8章 全球數位病理市場:各用途

  • 基礎研究、應用研究
  • 自動血液分析設備、血球計數器
  • 訓練、教育
  • 尿沉澱物分析
  • 醫療微生物學
  • 手術中諮詢
  • 遠程醫療諮詢
  • 定期性的診斷諮詢服務
  • 組織病理學
  • mHealth(行動醫療)
  • 藥物研發、醫藥品開發
  • 臨床病理學
  • 分子診斷
  • 螢光原位 雜合反應(FISH)列舉系統
  • 疫病診斷(癌症細胞檢測)
  • 化學的病理學

第9章 全球數位病理市場:各終端用戶

  • 醫院、參照實驗室
    • 500地板以上
    • 200~500地板
    • 不滿200地板
  • 製藥、生物科技企業
  • 診所
  • 學術、調查機關
  • 受託調查機關(CRO)
  • 法醫學研究所
    • 公立研究所
    • 民間研究所
  • 地質學

第10章 全球數位病理市場:各地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他

第11章 主要發展

  • 契約,夥伴關係,聯盟,合資企業
  • 收購、合併
  • 新產品的銷售
  • 事業擴張
  • 其他重要策略

第12章 企業簡介

  • XIFIN, Inc.
  • Visiopharm A/S
  • Sectra AB
  • PathAI
  • OptraSCAN
  • Akoya Biosciences
  • Leica Biosystems
  • Koninklijke Philips N.V.
  • Inspirata, Inc.
  • Indica Labs
  • Huron Digital Pathology
  • Apollo Enterprise Imaging
  • Glencoe Software
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Corista
  • Hamamatsu Photonics
  • Aiforia Technologies Oy
  • 3DHISTECH
  • Objective Pathology Services
Product Code: SMRC21381

According to Stratistics MRC, the Global Digital Pathology Market is accounted for $761.59 million in 2021 and is expected to reach $2050.63 million by 2028 growing at a CAGR of 15.2% during the forecast period. Digital pathology is a computer-enabled, image-based information platform that helps in the management of information generated from digital slides. Digital pathology will facilitate cutting back human error yet manufacturing precise diagnostic leads to a short turnaround. The processes concerned in digital pathology enable to hurry up routine tasks while not reducing the standard of the execution of every task.

Market Dynamics:

Driver:

Technological advancements

Technological advancements in digital pathology help to overcome limitations as these systems provide efficient and effective results for diagnostic tests. Manual interpretation of tissue slides for disease diagnosis purposes is costly and labor extensive that increases error and inconsistency in the diagnostic result and increases the risk of diagnostic failure and impedes the decision-making process. Digital pathology systems can analyze a large array of slides within a short duration without any diagnostic error.

Restraint:

High cost of digital pathology systems

The high cost associated with technologically advanced digital pathology systems is expected to restrain the growth of the digital pathology market. The average cost of the digital pathology systems for telepathology and whole slide imaging can be unaffordable for many low-resource environments in developing countries. Moreover, the digital pathology systems require costly infrastructure such as larger memory to store data, thereby restricting the usage of digital pathology systems this is leading to restraining the growth of the market.

Opportunity:

Introduction of affordable scanners

The development of affordable scanners is expected to offer growth opportunities for players operating in the digital pathology market. Most private medical practices are small businesses and cannot afford expensive digital pathology systems. The introduction of affordable scanners and the propensity of small players to move towards digitization of pathology workflow will encourage its adoption among pathologists with low or limited budgets.

Threat:

Shortage of trained pathologists

Pathologists play a crucial role in performing laboratory tests essential for disease diagnosis. However, there is a gap between the supply and demand of pathologists worldwide. Digital pathology enables medical practitioners to remotely share important information with pathologists beyond geographical boundaries securely and timely. Moreover, advanced technologies, such as AI and machine learning, help pathologists identify diseases faster and help improve their efficacy and efficiency. Thus, the alarming shortage of pathologists is expected to result in the increased utilization of digital pathology for providing remote pathological consultation and services.

The human pathology segment is expected to be the largest during the forecast period

The human pathology segment is estimated to have a lucrative growth owing to the increasing number of cancer research activities and growing collaborations among research institutes, universities, and pathology laboratories. With particular support for education, tissue-based research, drug development, and the profession of human pathology across the world, digital pathology is quickly gaining traction as a proven and important technology.

The pharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical & biotechnology companies segment is anticipated to witness the fastest CAGR growth during the forecast period due to the increasing use of digital pathology for drug discovery studies and drug toxicology testing, the rise in the prevalence of cancer, and the high demand for better treatment options. Biotechnology companies also use digital pathology for biobanking, biopharmaceutical studies, molecular assays, and the development of individualized medicine.

Region with highest share:

North America is projected to hold the largest market share during the forecast period due to the rise in the number of various types of cancer cases, increasing demand for quality diagnostics, the introduction of favorable reimbursement policies, the presence of key players, and the implementation of favorable initiatives by the governments in the US and Canada.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period owing to the rising penetration of digital imaging in emerging economies, investments in the medical field, and the presence of untapped opportunities. The presence of a large target patient population and booming healthcare industry is encouraging the growth of the regional market.

Key players in the market

Some of the key players profiled in the Digital Pathology Market include XIFIN, Inc., Visiopharm A/S, Sectra AB, PathAI, OptraSCAN, Akoya Biosciences, Leica Biosystems, Koninklijke Philips N.V., Inspirata, Inc., Indica Labs, Huron Digital Pathology, Apollo Enterprise Imaging, Glencoe Software, F. Hoffmann-La Roche Ltd., Corista, Hamamatsu Photonics, Aiforia Technologies Oy, 3DHISTECH and Objective Pathology Services.

Key Developments:

In September 2021, Visiopharm A/S collaborated with Agilent Technologies, Inc. (US) to co-market Visiopharm's portfolio of CE-IVD marked AI-driven Precision Pathology software and Agilent's automated pathology staining solutions portfolio.

In May 2021, Sectra AB signed an agreement with Institut Curie which allows the digitization of pathology at Institut Curie. The pathologists in Institut Curie can access cases, digital tools, and AI applications through the Sectra pathology solution.

Types Covered:

  • Veterinary Pathology
  • Human Pathology

Products Covered:

  • Software
  • Storage & Communication Systems
  • Services
  • Equipment

Deployments Covered:

  • On-premise
  • Cloud-based

Applications Covered:

  • Basic & Applied Research
  • Automated Hematology Analyzers & Blood Cell Counters
  • Training & Education
  • Urine Sediment Analysis
  • Medical Microbiology
  • Intraoperative Consultation
  • Teleconsultation
  • Routine Diagnostic Consultation Services
  • Histopathology
  • Mhealth (Mobile Health)
  • Drug Discovery & Development
  • Clinical Pathology
  • Molecular Diagnostics
  • Fish Enumeration Systems
  • Disease Diagnosis (Cancer Cell Detection)
  • Chemical Pathology

End Users Covered:

  • Hospitals and Reference Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Clinics
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)
  • Forensic Laboratories
  • Geology

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digital Pathology Market, By Type

  • 5.1 Introduction
  • 5.2 Veterinary Pathology
  • 5.3 Human Pathology

6 Global Digital Pathology Market, By Product

  • 6.1 Introduction
  • 6.2 Software
    • 6.2.1 Standalone Software
      • 6.2.1.1 Image Viewing and Analysis Softwares
      • 6.2.1.2 Information Management Software
    • 6.2.2 Integrated Software
  • 6.3 Storage & Communication Systems
  • 6.4 Services
    • 6.4.1 Maintenance and Validation Services
    • 6.4.2 Installation and Integration Services
    • 6.4.3 Consulting Services
  • 6.5 Equipment
    • 6.5.1 Histology equipment
    • 6.5.2 Whole Slide Scanners
      • 6.5.2.1 Brightfield
      • 6.5.2.2 Fluorescence
      • 6.5.2.3 Combination
    • 6.5.3 Clinical Microscope
      • 6.5.3.1 Digital Holography
      • 6.5.3.2 Digital Cytopathology
    • 6.5.4 Telepathology
      • 6.5.4.1 Dynamic
      • 6.5.4.2 Static
    • 6.5.5 Tissue Microarrays

7 Global Digital Pathology Market, By Deployment

  • 7.1 Introduction
  • 7.2 On-premise
  • 7.3 Cloud-based

8 Global Digital Pathology Market, By Application

  • 8.1 Introduction
  • 8.2 Basic & Applied Research
  • 8.3 Automated Hematology Analyzers & Blood Cell Counters
  • 8.4 Training & Education
  • 8.5 Urine Sediment Analysis
  • 8.6 Medical Microbiology
  • 8.7 Intraoperative Consultation
  • 8.8 Teleconsultation
  • 8.9 Routine Diagnostic Consultation Services
  • 8.10 Histopathology
  • 8.11 Mhealth (Mobile Health)
  • 8.12 Drug Discovery & Development
  • 8.13 Clinical Pathology
  • 8.14 Molecular Diagnostics
  • 8.15 Fish Enumeration Systems
  • 8.16 Disease Diagnosis (Cancer Cell Detection)
  • 8.17 Chemical Pathology

9 Global Digital Pathology Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals and Reference Laboratories
    • 9.2.1 >500 Beds
    • 9.2.2 200-500 Beds
    • 9.2.3 <200 Beds
  • 9.3 Pharmaceutical & Biotechnology Companies
  • 9.4 Clinics
  • 9.5 Academic & Research Institutes
  • 9.6 Contract Research Organizations (CROs)
  • 9.7 Forensic Laboratories
    • 9.7.1 Public Laboratories
    • 9.7.2 Private Laboratories
  • 9.8 Geology

10 Global Digital Pathology Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 XIFIN, Inc.
  • 12.2 Visiopharm A/S
  • 12.3 Sectra AB
  • 12.4 PathAI
  • 12.5 OptraSCAN
  • 12.6 Akoya Biosciences
  • 12.7 Leica Biosystems
  • 12.8 Koninklijke Philips N.V.
  • 12.9 Inspirata, Inc.
  • 12.10 Indica Labs
  • 12.11 Huron Digital Pathology
  • 12.12 Apollo Enterprise Imaging
  • 12.13 Glencoe Software
  • 12.14 F. Hoffmann-La Roche Ltd. (Switzerland)
  • 12.15 Corista
  • 12.16 Hamamatsu Photonics
  • 12.17 Aiforia Technologies Oy
  • 12.18 3DHISTECH
  • 12.19 Objective Pathology Services

List of Tables

  • Table 1 Global Digital Pathology Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Digital Pathology Market Outlook, By Type (2020-2028) ($MN)
  • Table 3 Global Digital Pathology Market Outlook, By Veterinary Pathology (2020-2028) ($MN)
  • Table 4 Global Digital Pathology Market Outlook, By Human Pathology (2020-2028) ($MN)
  • Table 5 Global Digital Pathology Market Outlook, By Product (2020-2028) ($MN)
  • Table 6 Global Digital Pathology Market Outlook, By Software (2020-2028) ($MN)
  • Table 7 Global Digital Pathology Market Outlook, By Standalone Software (2020-2028) ($MN)
  • Table 8 Global Digital Pathology Market Outlook, By Integrated Software (2020-2028) ($MN)
  • Table 9 Global Digital Pathology Market Outlook, By Storage & Communication Systems (2020-2028) ($MN)
  • Table 10 Global Digital Pathology Market Outlook, By Services (2020-2028) ($MN)
  • Table 11 Global Digital Pathology Market Outlook, By Maintenance and Validation Services (2020-2028) ($MN)
  • Table 12 Global Digital Pathology Market Outlook, By Installation and Integration Services (2020-2028) ($MN)
  • Table 13 Global Digital Pathology Market Outlook, By Consulting Services (2020-2028) ($MN)
  • Table 14 Global Digital Pathology Market Outlook, By Equipment (2020-2028) ($MN)
  • Table 15 Global Digital Pathology Market Outlook, By Histology equipment (2020-2028) ($MN)
  • Table 16 Global Digital Pathology Market Outlook, By Whole Slide Scanners (2020-2028) ($MN)
  • Table 17 Global Digital Pathology Market Outlook, By Clinical Microscope (2020-2028) ($MN)
  • Table 18 Global Digital Pathology Market Outlook, By Telepathology (2020-2028) ($MN)
  • Table 19 Global Digital Pathology Market Outlook, By Tissue Microarrays (2020-2028) ($MN)
  • Table 20 Global Digital Pathology Market Outlook, By Deployment (2020-2028) ($MN)
  • Table 21 Global Digital Pathology Market Outlook, By On-premise (2020-2028) ($MN)
  • Table 22 Global Digital Pathology Market Outlook, By Cloud-based (2020-2028) ($MN)
  • Table 23 Global Digital Pathology Market Outlook, By Application (2020-2028) ($MN)
  • Table 24 Global Digital Pathology Market Outlook, By Basic & Applied Research (2020-2028) ($MN)
  • Table 25 Global Digital Pathology Market Outlook, By Automated Hematology Analyzers & Blood Cell Counters (2020-2028) ($MN)
  • Table 26 Global Digital Pathology Market Outlook, By Training & Education (2020-2028) ($MN)
  • Table 27 Global Digital Pathology Market Outlook, By Urine Sediment Analysis (2020-2028) ($MN)
  • Table 28 Global Digital Pathology Market Outlook, By Medical Microbiology (2020-2028) ($MN)
  • Table 29 Global Digital Pathology Market Outlook, By Intraoperative Consultation (2020-2028) ($MN)
  • Table 30 Global Digital Pathology Market Outlook, By Teleconsultation (2020-2028) ($MN)
  • Table 31 Global Digital Pathology Market Outlook, By Routine Diagnostic Consultation Services (2020-2028) ($MN)
  • Table 32 Global Digital Pathology Market Outlook, By Histopathology (2020-2028) ($MN)
  • Table 33 Global Digital Pathology Market Outlook, By Mhealth (Mobile Health) (2020-2028) ($MN)
  • Table 34 Global Digital Pathology Market Outlook, By Drug Discovery & Development (2020-2028) ($MN)
  • Table 35 Global Digital Pathology Market Outlook, By Clinical Pathology (2020-2028) ($MN)
  • Table 36 Global Digital Pathology Market Outlook, By Molecular Diagnostics (2020-2028) ($MN)
  • Table 37 Global Digital Pathology Market Outlook, By Fish Enumeration Systems (2020-2028) ($MN)
  • Table 38 Global Digital Pathology Market Outlook, By Disease Diagnosis (Cancer Cell Detection) (2020-2028) ($MN)
  • Table 39 Global Digital Pathology Market Outlook, By Chemical Pathology (2020-2028) ($MN)
  • Table 40 Global Digital Pathology Market Outlook, By End User (2020-2028) ($MN)
  • Table 41 Global Digital Pathology Market Outlook, By Hospitals and Reference Laboratories (2020-2028) ($MN)
  • Table 42 Global Digital Pathology Market Outlook, By >500 Beds (2020-2028) ($MN)
  • Table 43 Global Digital Pathology Market Outlook, By 200-500 Beds (2020-2028) ($MN)
  • Table 44 Global Digital Pathology Market Outlook, By <200 Beds (2020-2028) ($MN)
  • Table 45 Global Digital Pathology Market Outlook, By Pharmaceutical & Biotechnology Companies (2020-2028) ($MN)
  • Table 46 Global Digital Pathology Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 47 Global Digital Pathology Market Outlook, By Academic & Research Institutes (2020-2028) ($MN)
  • Table 48 Global Digital Pathology Market Outlook, By Contract Research Organizations (CROs) (2020-2028) ($MN)
  • Table 49 Global Digital Pathology Market Outlook, By Forensic Laboratories (2020-2028) ($MN)
  • Table 50 Global Digital Pathology Market Outlook, By Public Laboratories (2020-2028) ($MN)
  • Table 51 Global Digital Pathology Market Outlook, By Private Laboratories (2020-2028) ($MN)
  • Table 52 Global Digital Pathology Market Outlook, By Geology (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.